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The choroid plexus, an epithelial-based structure localized in the brain ventricle, is the
major component of the blood-cerebrospinal fluid barrier. The choroid plexus produces
the cerebrospinal fluid and regulates the components of the cerebrospinal fluid. Abnormal
choroid plexus function is associated with neurodegenerative diseases, tumor formation
in the choroid plexus epithelium, and hydrocephaly. In this study, we used zebrafish
(Danio rerio) as a model system to understand the genetic components of choroid
plexus development. We generated an enhancer trap line, Et(cp:EGFP)sj2, that expresses
enhanced green fluorescent protein (EGFP) in the choroid plexus epithelium. Using
immunohistochemistry and fluorescent tracers, we demonstrated that the zebrafish
choroid plexus possesses brain barrier properties such as tight junctions and transporter
activity. Thus, we have established zebrafish as a functionally relevant model to study
choroid plexus development. Using an unbiased approach, we performed a forward
genetic dissection of the choroid plexus to identify genes essential for its formation and
function. Using Et(cp:EGFP)sj2, we isolated 10 recessive mutant lines with choroid plexus
abnormalities, which were grouped into five classes based on GFP intensity, epithelial
localization, and overall choroid plexus morphology. We also mapped the mutation for
two mutant lines to chromosomes 4 and 21, respectively. The mutants generated in this
study can be used to elucidate specific genes and signaling pathways essential for choroid
plexus development, function, and/or maintenance and will provide important insights into
how these genetic mutations contribute to disease.
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INTRODUCTION
The choroid plexus consists of polarized epithelial cells pro-
jecting into the brain ventricle to create a blood-cerebrospinal
fluid barrier between fenestrated capillaries and the cerebrospinal
fluid (Wolburg and Paulus, 2010). These epithelial cells are mod-
ified ependymal cells derived from embryonic neuroepithelial
cells that form intercellular tight junctions and express multiple
families of transporters that create both a physical and chemi-
cal barrier. The choroid plexus also plays an important role in
the production and secretion of the cerebrospinal fluid and the
regulation of central nervous system homeostasis. Although the
choroid plexus of the lateral brain ventricles was documented
by Herophilus, an ancient Greek physician (Dohrmann, 1970;
Dziegielewska et al., 2001), there has been little research aimed
toward identifying the genetic pathways essential for choroid
Abbreviations: Cldn5, Claudin 5; CNS, central nervous system; CP, choroid
plexus; CPe, choroid plexus epithelium; CSF, cerebrospinal fluid; dpf, days post-
fertilization; dCP, diencephalic choroid plexus; EGFP, enhanced green fluores-
cent protein; Et(cp:EGFP)sj2, Enhancer trap(choroid plexus:enhanced green flu-
orescent protein)sj2; hpf, hours post-fertilization; mCP, myelencephalic choroid
plexus; MDR1, Multidrug Resistance Transporter 1; MRP1, Multidrug Resistance-
Associated Protein 1; OAT3, Organic Anion Transporter 3; PTU, N-Phenylthiourea.
plexus formation and function. Previous studies have classified
choroid plexus development by observing modifications in cell
morphology, measuring glycogen content as it matures, and
examining gene expression (Dohrmann, 1970; Strazielle and
Ghersi-Egea, 2000; Dziegielewska et al., 2001; Kratzer et al., 2012,
2013; Liddelow et al., 2014). Signaling pathways such as Sonic
hedgehog (Huang et al., 2009; Nielsen and Dymecki, 2010), BMP
(Currle et al., 2005), and Notch (Irvin et al., 2004) have been
found to contribute to choroid plexus formation. However, how
these pathways interact with one another to generate the choroid
plexus and the downstream components involved in its develop-
ment, function, and maintenance are unknown. Understanding
normal development and function in the choroid plexus is cru-
cial to unraveling how these mechanisms become altered in
diseases. The choroid plexus has been associated with various
disease conditions, including choroid plexus tumors (Wolburg
and Paulus, 2010), hydrocephalus (Wodarczyk et al., 2009), and
neurodegenerative diseases such as Alzheimer’s disease (Alvira-
Botero and Carro, 2010) and multiple sclerosis (Vercellino et al.,
2008). Identifying altered genes and signaling pathways in the
choroid plexus that cause disease initiation or progression can
help determine potential therapeutic targets for treatment.
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Models used to study the choroid plexus have included (1)
mice, because of their similarity to the human choroid plexus in
gene expression patterns (Janssen et al., 2013); (2) marsupials,
because post-natal lateral ventricle development occurs outside
of the womb (Liddelow et al., 2010); and (3) in vitro cell cul-
ture systems to study choroid plexus transport (Monnot and
Zheng, 2013). However, these models do not provide real-time,
in vivo developmental information. We propose, as have oth-
ers (Bill et al., 2008; Garcia-Lecea et al., 2008), that zebrafish
are a suitable vertebrate model to analyze and genetically dissect
choroid plexus development and function in vivo, as they offer
several advantages such as having central nervous system struc-
tures similar to those in mammals, rapid ex utero development,
transparency, large numbers of offspring, and genetic tractability
(Goldsmith and Jobin, 2012).
Previous studies have examined the role of Shh and Notch sig-
naling in choroid plexus development using zebrafish (Bill et al.,
2008; Garcia-Lecea et al., 2008). However, these studies did not
examine functional choroid plexus barrier properties such as tight
junctions and transporters. Here, we generated an enhancer trap
line, Et(cp:EGFP)sj2, that expresses enhanced green fluorescent
protein (EGFP) in epithelial cells of the diencephalic choroid
plexus and myelencephalic choroid plexus. We used this enhancer
trap line to visualize choroid plexus development in vivo and
demonstrated that several components of the zebrafish choroid
plexus are comparable to human. We also performed a small-
scale ENU-mutagenesis screen and identified 10 recessive mutant
lines. These mutants were classified into five categories on the
basis of EGFP expression and choroid plexus morphology. We
also genetically mapped the mutations from two mutant lines
using bulked-segregant analysis. The cloning and characterization
of these mutants will provide important insights into the genetic
pathways that regulate formation and function of the choroid
plexus in health and disease.
MATERIALS AND METHODS
FISH LINES AND MAINTENANCE
Zebrafish were maintained at 28.5◦ on a 14 h light/dark cycle.
Embryos used for imaging or for screening F3 larvae were col-
lected in egg water (0.03% Instant Ocean) containing 0.02%
methylene blue and treated at 24 h post-fertilization (hpf) with
0.003% 1-phenyl-2-thiourea (PTU) (Sigma) to prevent pigment
formation. Zebrafish were maintained in accordance with estab-
lished protocols and all experiments were approved by the St. Jude
Children’s Research Hospital Institutional Animal Care and Use
Committee.
GENERATION OF THE Et(cp:EGFP)sj2 LINE
To generate the Et(cp:EGFP)sj2 line, EGFP was released from
the pEGFP-N1 vector (Clontech) by BamHI and NotI diges-
tion and inserted into the pTRE-Tight vector (Clontech). The
TRE-tight:EGFP fragment was released by XhoI and ClaI diges-
tion and inserted into the pT2AL200R150G vector (Urasaki
et al., 2006). Approximately 30 pg of the resulting T2 (TRE-
tight:EGFP) plasmid DNA was co-injected with 30 pg of in vitro
transcribed Tol2 transposase mRNA into single-cell embryos of
the AB strain. The embryos were raised to adults and screened
for germline transmission by examining their offspring for EGFP
expression.
IMMUNOHISTOCHEMISTRY (IHC)
Larvae were anesthetized in 0.02% tricaine and fixed in 4%
paraformaldehyde (PFA) (Electron Microscopy Sciences) at
4◦ overnight and washed the next day in 1× phosphate
buffered serum (PBS) (Calbiochem). Samples were sunk in 30%
sucrose/PBS at 4◦ overnight. Larval 1-month-old brain tissues,
and adult brains were embedded in Optimal Cutting Temperature
(O.C.T.) Compound (Tissue-Tek), frozen on dry ice, and stored
at −80◦. Tissues were sectioned using a Leica CM 1950 cryostat.
Sections were washed in PBS for 5min followed by three 5min
washes in PBST [PBS/0.03% Triton X-100 (Sigma)]. Sections
were incubated in blocking buffer [PBST with 5% goat serum
(Gibco) and 1% BSA (Sigma)] for 3 h at room temperature.
Primary antibodies were incubated at 4◦ overnight followed by
secondary antibody incubation for 2 h at room temperature.
Sections were washed in PBST four times for 15min after pri-
mary and secondary antibody incubations. Primary antibodies
included rabbit anti-GFP (1:500; Invitrogen) and mouse anti-
Zpr1 (1:100; ZIRC). Secondary antibodies included Alexa Fluor
goat anti-rabbit 488 (1:200; Invitrogen) and Alexa Fluor goat anti-
mouse 555 (1:200; Invitrogen). Antibody dilutions were prepared
in blocking buffer. Sections were counterstained with 1μg/mL
DAPI (Roche) for 1min, rinsed briefly in PBS, and mounted with
Fluoromount (Electron Microscopy Sciences). Images were taken
on a Nikon AZ100 microscope and analyzed using NIS-Elements
AR 3.2 software.
WHOLE-MOUNT IHC
Embryos were incubated in egg water with 0.003% PTU to pre-
vent pigment formation. At 4 and 6 days post-fertilization (dpf),
larvae were anesthetized in 0.02% tricaine and fixed in 4% PFA
overnight. The next day, samples were washed in 1× PBS fol-
lowed by 1× PBST and treated with 20μg/mL Proteinase K
(New England Biolabs) for 15min. The reaction was stopped by
adding 10% lamb serum (Gibco) followed by additional washes
in PBST. Samples were blocked with 10% lamb serum for 1–4 h
and incubated in primary antibody at 4◦ overnight. Samples
were washed the next day in PBST and incubated in secondary
antibody at 4◦ overnight. Antibodies used included rabbit anti-
GFP (1:100; Invitrogen), mouse anti-Zpr1 (1:50; ZIRC), mouse
anti-Cldn5 (1:100; Invitrogen), Alexa Fluor goat anti-rabbit 488
(1:200; Invitrogen), and Alexa Fluor goat anti-mouse 555 (1:200;
Invitrogen). Additional washes in PBST were done the following
day and stored in 1× PBS. Samples were embedded in 0.8% low-
melting point agarose (Invitrogen) made in 1× PBS and imaged
on Nikon C1Si laser scanning confocal microscope. Z-stacks were
compiled to create maximum intensity projection images using
Nikon NIS-Elements 3.1 imaging software.
FLUORESCENT TRACER INJECTIONS
To observe transporter activity in the choroid plexus,
Et(cp:EGFP)sj2 larvae at 4 dpf were anesthetized in 0.02%
tricaine and injected intravenously into the common cardinal
vein with approximately 1–2 nL of 100μM rhodamine 123
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(Sigma-Aldrich) using a micromanipulator and a pneumatic
picopump (World Precision Instruments). The total blood
volume of zebrafish embryos at 2 dpf has been estimated to be
60 nL (Craig et al., 2012), so the blood volume is not significantly
altered upon injection. Immediately after the injections, larvae
were embedded in 1.2% low-melting-point agarose (Invitrogen)
made in egg water. Larvae were imaged on a Nikon C1Si confocal
microscope and analyzed using Nikon EZC1 3.91 software.
To study choroid plexus function, Casper larvae (lacking
melanocytes and iridophores) (White et al., 2008) were anes-
thetized in 0.02% tricaine and intravenously injected into the
common cardinal vein with approximately 0.3–2 nL of 10mg/mL
rhodamine- and fluorescein-labeled dextrans at 2, 3, and 4 dpf.
Fluorescent tracers included a 3-kDa fluorescein dextran, a
10-kDa rhodamine dextran, and a 40-kDa anionic fluorescein
dextran (Invitrogen). Immediately after the injections, larvae
were laterally embedded in 1.2% low-melting-point agarose made
in egg water. To observe tracer permeability into the brain ven-
tricle, time-lapse images were collected every 2min for 1 h with
a Nikon AZ100 microscope equipped with a shutter (Sutter
Instruments) and analyzed with Nikon NIS-Elements 3.2 soft-
ware. Et(cp:EGFP)sj2 larvae were also injected intravenously with
the 10-kDa rhodamine dextran at 2 and 4 dpf and imaged
on a Nikon C1Si confocal microscope with Nikon EZC1 3.91
software.
To visualize brain ventricle morphology in wild-type and
mutant Et(cp:EGFP)sj2, PTU-treated larvae at 4 dpf were anes-
thetized and intraventricularly injected with approximately 2 nL
of 40-kDa fluorescein-labeled dextran as described previously
(Gutzman and Sive, 2009). Larvae were imaged immediately after
the injection using a Nikon SMZ1500 epifluorescence stereomi-
croscope and analyzed with Nikon NIS-Elements 3.1 software.
Ventricular injections of rhodamine 123 and fluorescein were
performed as described previously (Gutzman and Sive, 2009) in
Casper larvae at 4 dpf and imaged on a Nikon C1Si confocal
microscope with Nikon EZC1 3.91 software.
FLUORESCEIN TREATMENT
Casper and Et(cp:EGFP)sj2 larvae were incubated for 4 h in
the dark with 50μM fluorescein (Fluka). Larvae were briefly
rinsed 12 times in egg water, anesthetized in 0.02% tricaine,
and embedded in 1.2% low-melting-point agarose. After 30min,
larvae were imaged using a Nikon SMZ1500 epifluorescence
stereomicroscope and analyzed with Nikon NIS-Elements 3.1
software.
STATISTICAL ANALYSIS OF TRACER PERMEABILITY
The ratio of the fluorescence intensity in the ventricle to that in
the heart was calculated at the 30-min timepoint when the leakiest
tracer reached saturation. The ratio was then normalized against
the tracer having the greatest mean intensity in the ventricle at
30min. A One-Way ANOVA test was performed in Microsoft
Excel to determine whether there was a significant difference
in fluorescent intensity between the tracers and developmental
timepoints. A Tukey’s post-hoc test was performed to determine
which tracers were statistically significant to one another at each
developmental timepoint. A significance value of α = 0.05 was
used, and P-values were calculated using the GraphPad software
P-value calculator. Error bars were based on the mean of 7
observations using standard error.
N-ETHYL-N-NITROSOUREA (ENU) MUTAGENESIS AND FORWARD
GENETIC SCREENING
Twenty Et(cp:EGFP)sj2 males were treated three times with 3mM
ENU (Sigma) for 1 h each at weekly intervals as described pre-
viously (Driever et al., 1996). After 1 month, ENU-treated males
were mated to Et(cp:EGFP)sj2 females to produce the F1 genera-
tion. F1 pairwise crosses were performed to produce F2 families.
F2 families that did not contain at least 4 male/female pairs were
sacrificed. Pairwise crosses for each F2 family were done at least
six times if possible to identify F3 offspring with homozygous
recessive mutations. F2 pairs deemed heterozygous for a reces-
sive mutation were maintained in miniboxes for use in genetic
mapping experiments. To screen for choroid plexus mutants, F3
larvae at 4 dpf were anesthetized and visualized using a Nikon
SMZ1500 epifluorescence stereomicroscope to identify abnormal
GFP expression or patterning in the choroid plexus. A mutant
line was confirmed if approximately 25% of the total offspring
displayed a choroid plexus phenotype.
GENOMIC DNA ISOLATION
Adult zebrafish were anesthetized in 0.02% tricaine (Sigma-
Aldrich) and tail clipped. As the fish recovered in system water,
the tail clip was immediately immersed into 50μL digest buffer
(0.2M NaCl, 10mM Tris 8.0, 5mM EDTA, 0.1% SDS, 0.1mg/ml
Proteinase K). Samples were incubated overnight at 50◦. After
brief centrifugation, 450μL of 100% ethanol (EtOH) added.
Samples were centrifuged at 21,130 g for 10min, the supernatant
was removed, and 500μL of 70% EtOH added to wash the pel-
let. Samples were centrifuged at 21,130 g or 15,000 rpm for 5min.
After removing the supernatant, the samples were stored at room
temperature for about 30min to evaporate excess EtOH. The
DNA pellets were resuspended with 50μL of TE buffer (10mM
Tris and 1mM EDTA, pH 8.0).
For zebrafish larvae, wild-type and mutants were anesthetized,
separated into 1.5mL eppendorf tubes, and immersed in 1mL
100% methanol (MeOH) (Sigma-Aldrich). Samples were stored
at −20◦ overnight. The following day, individual wild-type and
mutant larvae were transferred into 0.5mL tubes and the excess
MeOH removed. Once all the MeOH evaporated, 10μL of digest
buffer (same as above) was added to each tube. Samples were
incubated overnight at 50◦. DNA was isolated as described above
for adults except the volume of 100% EtOH and 70% EtOH was
180μL and the volume of TE buffer was 25μL.
GENETIC MAPPING
After identifying a mutant line, the Et(cp:EGFP)sj2 F2 heterozy-
gous parents were each outcrossed to the polymorphic TL strain.
From this outcross, we identified AB/TL hybrids heterozygous
for the recessive mutation by screening their offspring. The wild-
type and mutant offspring from these heterozygous hybrids were
collected and their DNA was extracted (see above). A genome
scan using 192 polymorphic Z-markers was performed with
DNA pooled from 30 wild-type and 30 mutant larvae as pre-
viously described (Muto et al., 2005). Wild-type and mutant
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DNA was amplified using the Accuprime Taq DNA Polymerase
System (Invitrogen). The resulting PCR products were analyzed
for genetic linkage by agarose gel electrophoresis. For fine genetic
mapping, individual wild-type and mutant DNA was ampli-
fied using Platinum PCR Supermix (Invitrogen). Z-markers used
for genetic mapping were acquired from the zebrafish genome
database at www.ensembl.org. Additional markers were designed
by examining the Ensembl genome browser for polymorphic
regions in the genome.
LIVE CONFOCAL IMAGING AND TIME-LAPSE MOVIES
Confocal imaging was performed on a Nikon C1Si confocal
microscope and analyzed using Nikon EZC1 3.91 software. Scans
of DIC and GFP images were acquired using a 20× objective at
4μm intervals to create a z-stack maximum intensity projection
image. To observe choroid plexus development, larvae were col-
lected at ∼30 hpf and prepared for imaging as described above.
Z-stack images were acquired every 30min over a 65 h period.
Using NIS-Elements AR 4.0 software, images were smoothed and
z-stacks were compiled to create an enhanced depth of focus
(EDF) image. To compare choroid plexus development, wild-type
and mutant larvae were imaged beginning at 54 hpf with images
acquired every 30min over a 48 h period. Supplemental movies
run for the 48 h period except for Supplemental movie 6 which
runs for 42 h.
RESULTS
GENERATION AND CHARACTERIZATION OF THE ZEBRAFISH CHOROID
PLEXUS ENHANCER TRAP LINE Et(cp:EGFP)sj2
In the process of producing a tetracycline-inducible transgenic
line, we fortuitously generated the zebrafish choroid plexus line
by an enhancer trap effect where EGFP became “trapped” within
the genome and is now regulated by an enhancer. To generate this
line, we co-injected a TRE-EGFP construct with Tol2 transposase
mRNA into single-cell zebrafish embryos. The TRE-EGFP con-
struct was integrated into an enhancer region that regulates gene
expression in the choroid plexus. Using Southern blot analysis, we
identified a single TRE-EGFP insertion on chromosome 13 (data
not shown). By sequencing genes within this region, we identified
the TRE-GFP transgene between two genes TATA box binding pro-
tein (tbp) and asparaginase-like1 (asrgl1), both of which according
to zfin.org are not spatially restricted in their mRNA expression
patterns. After performing in situ hybridization on asrgl1, we
did not observe expression within the choroid plexus (data not
shown). Because we were unable to identify choroid plexus spe-
cific genes along this region of Chromosome 13, we concluded
that the GFP expression in the choroid plexus is the result of
an enhancer trap affect where an enhancer localized upstream
or downstream of GFP is regulating GFP expression. The inser-
tion was transmitted to subsequent generations, thereby creating
a stable line termed Et(cp:EGFP)sj2.
GFP expression was specifically localized to the diencephalic
choroid plexus in the third ventricle and the myelencephalic
choroid plexus in the fourth ventricle at 3 dpf corresponding
to the mammalian choroid plexus in third and fourth ventri-
cles, respectively (Figure 1A). We identified that this integration
resulted in EGFP expression in the diencephalic choroid plexus
and myelencephalic choroid plexus based on two previously pub-
lished papers also identifying GFP expression in the diencephalic
choroid plexus and myelencephalic choroid plexus of zebrafish
(Bill et al., 2008; Garcia-Lecea et al., 2008). Unlike mammals, the
zebrafish choroid plexus is dorsal to the brain allowing for easy
visualization of choroid plexus development. As mentioned in the
two previous zebrafish choroid plexus studies, the myelencephalic
choroid plexus in teleosts exists as a layer of GFP positive cells on
the dorsal surface of the fourth ventricle and ventral to the outer
skin epithelium, while the diencephalic choroid plexus is at the
most dorsal portion of the third ventricle (Bill et al., 2008; Garcia-
Lecea et al., 2008). This allows choroid plexus development to be
easily visualized in the zebrafish because it is not buried inside the
brain as in other vertebrates. Similarly as described in the dog-
fish shark, the myelencephalic choroid plexus lies over the brain
ventricle rather than obstructed between the medulla and cere-
bellum (Villalobos et al., 2002). Other studies on zebrafish brain
development describe how the development of the telencephalon
folds outward with the proliferating cells on the outside rather
than inward as seen in other vertebrates (Schmidt et al., 2013),
suggesting the zebrafish has more of an “inside out” morphol-
ogy. This type of development in zebrafish, termed the eversion
model, begins with brain ventricular formation followed by the
movement of surrounding neural tissue migrating into the ven-
tricle space and results in an overlying ventricle surrounding the
brain tissue (Folgueira et al., 2012). Because brain ventricular for-
mation occurs prior to choroid plexus development, the eversion
process may be responsible for this “inside out” morphology.
To gain further insight into the location of the choroid
plexus in relation to other central nervous system structures,
we used whole-mount immunohistochemistry (IHC) to stain
Et(cp:EGFP)sj2 larvae with a Zpr-1 antibody labeling cone pho-
toreceptors of the eye and the pineal gland. In other teleosts and
mammals, the pineal gland directly interacts with the choroid
plexus of the third ventricle (Omura et al., 1985; Skinner and
Malpaux, 1999). Although the diencephalic choroid plexus is dis-
tinct from the pineal gland, we found a close association between
the two structures, where the diencephalic choroid plexus was
found anterior to the pineal gland (Figure 1B). Transverse sec-
tions showed the diencephalic choroid plexus positioned beneath
the pineal gland (Figure 1C). Additional transverse sections
through the myelencephalic choroid plexus showed a cluster
of GFP-positive epithelial cells directly beneath the skin sur-
face (Figure 1D). GFP expression in the diencephalic choroid
plexus and myelencephalic choroid plexus was retained through-
out development and at later stages, as shown in a 1-month-old
Et(cp:EGFP)sj2 (Figures 1E,F).
To further demonstrate that this is indeed the choroid plexus,
we cut sections from adult brains and showed expression of
GFP in a structure historically referred to as the saccus dor-
salis (Figure 2). This structure is homologous to the mammalian
choroid plexus of the third ventricle. The saccus dorsalis in rain-
bow trout (Salmo gairdneri), has been described as a folded
monolayer of epithelium that develops out of the diencephalic
roof plate (Jansen et al., 1976). Because the saccus dorsalis has also
been described to partially cover the pineal stalk (Tsuneki, 1986),
similar to what we show in Figure 1B, we conclude that this is the
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FIGURE 1 | The Et(cp:EGFP)sj2 line expresses GFP in the diencephalic
choroid plexus and myelencephalic choroid plexus. (A) Confocal image
showing the dorsal view of the head of 3 dpf Et(cp:EGFP)sj2 larvae expressing
GFP in the diencephalic choroid plexus and myelencephalic choroid plexus.
(B) Whole-mount immunohistochemical staining of Et(cp:EGFP)sj2 larvae at
6 dpf. GFP in green labels the diencephalic choroid plexus and myelencephalic
choroid plexus, and Zpr-1 shown in red labels the pineal gland and
photoreceptors. The yellow overlay demonstrates the interaction between the
pineal gland and diencephalic choroid plexus. The solid and dashed lines
across the diencephalic choroid plexus and myelencephalic choroid plexus in
the inset image indicate approximate regions where sections were taken for
(C,D). (C) Transverse section through the diencephalic choroid plexus of 6 dpf
Et(cp:EGFP)sj2 larvae stained with GFP, DAPI, and Zpr-1. (D) Transverse
section through the myelencephalic choroid plexus of 6 dpf Et(cp:EGFP)sj2
larvae stained with GFP and DAPI. (E) Transverse section through the
diencephalic choroid plexus of a 1-month-old Et(cp:EGFP)sj2 zebrafish stained
with GFP and Zpr-1 to label the diencephalic choroid plexus and pineal gland,
respectively. (F) Transverse section through the myelencephalic choroid
plexus of a 1-month-old Et(cp:EGFP)sj2 zebrafish stained with GFP.
Abbreviations: diencephalic CP, diencephalic choroid plexus; mCP,
myelencephalic CP; GFP, green fluorescent protein; DAPI,
4′,6-diamidino-2-phenylindole; E, eye; F, forebrain; H, hindbrain. For all images:
filled arrowhead, diencephalic choroid plexus; open arrowhead, pineal gland;
arrow, myelencephalic choroid plexus. Scale bars are 50μm.
choroid plexus of the third ventricle in zebrafish. We also detected
GFP expression in the swimbladder (data not shown). The swim-
bladder consists of epithelial cells and has been compared to the
mammalian lung (Winata et al., 2009). Using time-lapse confocal
microscopy, GFP expression was detected in a subset of dien-
cephalic choroid plexus cells as early as 30 hpf (see Supplemental
Movie 1). We found that the myelencephalic choroid plexus
epithelial cells migrated from the outer rhombomeres into the
midbrain-hindbrain boundary as described previously (Garcia-
Lecea et al., 2008) and also anteriorly from the developing
spinal cord. These cells increase in GFP intensity as they coa-
lesce to form a compact structure by approximately 72 hpf. There
were no additional changes in choroid plexus morphology by
96 hpf.
ZEBRAFISH CHOROID PLEXUS EXPRESSES THE TIGHT JUNCTION
PROTEIN CLAUDIN 5 AND POSSESSES TRANSPORTER ACTIVITY
The mammalian choroid plexus expresses many tight-junction
proteins such as claudins (Lippoldt et al., 2000; Kratzer et al.,
2012), occludin (Lagaraine et al., 2011), and junction adhe-
sion molecules (Lagaraine et al., 2011). These tight junctions
create a physical barrier between the blood and cerebrospinal
fluid. To demonstrate that the zebrafish choroid plexus express
tight junction protein similar to mammals, we studied Claudin
5 (Cldn5) expression because of the availability of an antibody
that cross-reacts with zebrafish Cldn5 (Xie et al., 2010; Zhang
et al., 2010). As predicted, whole-mount IHC analysis revealed
Cldn5 expression at the cell membrane of zebrafish choroid
plexus epithelium (Figures 3A–C). Cldn5 expression was also
observed in the eyes, blood vessels, and neighboring ependymal
cells (Figures 3B,C).
In mice, multidrug resistance transporters, such as MRP1,
are expressed on the basolateral side of choroid plexus epithe-
lium and regulate drug accumulation in the cerebrospinal fluid
(Wijnholds et al., 2000). In addition to drug transport, MRP1 and
MDR1, efflux fluorescent dyes such as rhodamine 123 (Saengkhae
et al., 2003). To the best of our knowledge, no previous studies
have demonstrated transporter function in zebrafish choroid
www.frontiersin.org November 2014 | Volume 8 | Article 364 | 5
Henson et al. Zebrafish choroid plexus genetics
FIGURE 2 | The adult Et(cp:EGFP)sj2 expresses GFP in the saccus
dorsalis. Sagital sections through adult brains were labeled with
rabbit anti-GFP antibody (green) and counterstained with DAPI (blue).
(A,B) shows GFP expression in the adult CP of the third ventricle
taken through two different sagittal planes of the adult brain.
Dashed-line boxes refer to magnified images shown in (C,D). dCP:
diencephalic CP; F: forebrain; M: midbrain; H: hindbrain. Scale bars
are 100μm.
plexus. To determine whether transporters contribute to the
blood-cerebrospinal fluid barrier at the zebrafish choroid plexus,
we intravenously injected rhodamine 123 into the Et(cp:EGFP)sj2
line at 4 dpf and observed its accumulation within the choroid
plexus epithelium (Figures 3D–F). After injecting rhodamine 123
into the brain ventricle/cerebrospinal fluid, we also observed
accumulation in the choroid plexus (Figures 4A–D), indicating
that independent of what interface the rhodamine 123 resides
(whether blood or cerebrospinal fluid), the dye is transported by
the choroid plexus.
Another transporter that is highly expressed in the choroid
plexus is organic anion transporter 3 (OAT3) (Keep and Smith,
2011). Fluorescein, a known substrate for OAT3, is taken up by
the transporter on the apical side of the choroid plexus epithelium
in a Na+-dependent manner (Sykes et al., 2004). Because fluores-
cein is a low-molecular-weight green fluorescent dye, we soaked
Casper zebrafish in 50μMfluorescein to observe accumulation in
the choroid plexus. The dye was ingested in the gut, entered the
circulation, and concentrated in the diencephalic choroid plexus
and myelencephalic choroid plexus (Figures 3G,H). Fluorescein
injected into the brain ventricle had a similar pattern of accu-
mulation in the myelencephalic choroid plexus and diencephalic
choroid plexus (Figures 4E–H).
ZEBRAFISH CHOROID PLEXUS POSSESSES SIZE-SELECTIVE BARRIER
PROPERTIES
To examine the function of the zebrafish choroid plexus in reg-
ulating passage from the bloodstream into the cerebrospinal
fluid, we intravenously injected fluorescently labeled dextrans of
various molecular weights into the transparent Casper line at 2,
3, and 4 dpf. Time-lapse imaging at 2 dpf, before the choroid
plexus has fully developed, showed that 3-kDa fluorescein and
10-kDa rhodamine dextrans leaked from the bloodstream into
the brain ventricle, whereas little to no 40-kDa fluorescein dex-
tran escaped from the bloodstream into the ventricle (Figure 5A).
By 3 dpf, there was still a significant difference with a P-value
of < 0.0001 between the 3- and 10-kDa dextrans and the 40-
kDa dextran; however, the overall permeability was lower at 3 dpf
compared to 2 dpf (Figure 5B). By 4 dpf, when the choroid plexus
was fully formed, there were no significant differences between
the individual tracers (Figure 5B). Dorsal views of an intravenous
injection of the 10-kDa dextran into Et(cp:EGFP)sj2 larvae at 2 dpf
showed leakage into the brain ventricle as the choroid plexus
continued to develop. Once formed by 4 dpf, dextran did not
accumulate within the brain ventricle (Figure 6A). In addition,
the 3- and 10-kDa dextrans were significantly more permeable
at 2 dpf (P < 0.0001) compared to 3 and 4 dpf, but there was
no significant difference in permeability for the 40-kDa dextran
(Figure 6B).
IDENTIFICATION OF CHOROID PLEXUS MUTANTS
After demonstrating that the zebrafish choroid plexus develops
and functions as the blood-cerebrospinal fluid barrier begin-
ning at 3 dpf, we initiated a small-scale forward genetic screen to
identify mutants with choroid plexus abnormalities. This screen
focused primarily on myelencephalic choroid plexus defects.
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FIGURE 3 | The zebrafish CP possesses tight junction and transporter
properties. (A) Whole-mount immunohistochemical staining of
Et(cp:EGFP)sj2 larvae at 4 dpf with GFP labeling the diencephalic choroid
plexus and myelencephalic choroid plexus. (B) Whole-mount
immunohistochemical staining with Claudin 5 antibody (red) showed
expression in the eye (arrow), surface vessels (arrowhead), and CP. (C)
Overlay of GFP and Claudin 5 staining revealed Claudin 5 expression
surrounding the perimeter of CPe and ependymal cells. Examples of
ependymal cells are shown with an asterisk (∗). Images in (A,B) taken at 20×
magnification and (C) at 40× magnification. (D) Live imaging of
Et(cp:EGFP)sj2 larvae at 4 dpf showed GFP expression in the CP. (E,F)
Accumulation of rhodamine 123 in the diencephalic choroid plexus
(arrowhead) and myelencephalic choroid plexus (arrow). (G) Side view of live
Casper zebrafish treated at 4 dpf with 50μM fluorescein for 4 h showed
accumulation of fluorescein (represented in green) in the diencephalic
choroid plexus (filled arrowhead) and myelencephalic choroid plexus (arrow)
along with the gut (asterisk), and lateral line (open arrowhead). (H) Similar
image as in (G) except for dorsal view showing accumulation in the
diencephalic choroid plexus (filled arrowhead), myelencephalic choroid plexus
(arrow), and overlying vasculature (open arrowhead). Abbreviations: dCP,
diencephalic CP; mCP, myelencephalic CP; E, eye; OV; Otic vesicle. Scale bar
in A and H is 50μm. Scale bar in C is 20μm.
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FIGURE 4 | Rhodamine 123 and fluorescein ventricle injection
demonstrates transporter activity in the CP. Dorsal fluorescent (A) and
merged (bright-field and Rhodamine 123) (B) confocal image of 4 dpf Casper
larvae with Rhodamine 123 (red) injection into the brain ventricle. The
rhodamine 123 concentrates within the myelencephalic choroid plexus
(arrowhead). Rhodamine 123 also fluoresces green and co-localizes with red
emission (not shown). Lateral fluorescent (C) and merged (bright-field and
Rhodamine 123) (D) confocal image of 4 dpf Casper larvae with Rhodamine
123 (red) injection into the brain ventricle. The rhodamine 123 concentrates
within the myelencephalic choroid plexus (arrowhead) and diencephalic
choroid plexus (arrow). Dorsal fluorescent (E) and merged (bright-field and
fluorescein) (F) confocal image of 4 dpf Casper larvae with fluorescein (green)
injected into the brain ventricle. Fluorescein concentrates within the
myelencephalic choroid plexus (arrowhead) and diencephalic choroid plexus
(arrow). Lateral fluorescent (G) and merged(bright-field and fluorescein)
(H) confocal image of 4 dpf Casper larvae with fluorescein (green) injected
into the brain ventricle. Fluorescein concentrates within the myelencephalic
choroid plexus (arrowhead) and diencephalic choroid plexus (arrow).
Abbreviations: mCP, myelencephalic choroid plexus; dCP, diencephalic choroid
plexus. Scale bar is 50μm.
Table 1 shows the numbers of fish generated from this screen.
Briefly, 20 F0 Et(cp:EGFP)sj2 males were mutagenized with ENU.
One month after treatment, ENU efficiency was tested by mating
the males to Casper and screening for nacre or roy pheno-
types. Approximately 1 in 250 (0.4%) larvae showed the nacre
or roy phenotype. The mutagenized males were mated with
Et(cp:EGFP)sj2 females to generate 409 F1 fish. Adult F1 pairs
were mated together or with non-mutagenized Et(cp:EGFP)sj2
fish to produce 224 F2 families. Of the F2 families, 73 contained
sufficient numbers to screen 4–6 pairs for mutants in the F3 gen-
eration. We set up 1330 F2 × F2 crosses (including re-crosses),
with 421 crosses producing F3 embryos. Larvae were screened at
4 dpf to identify choroid plexus defects based on GFP expression
patterns. In total, we generated approximately16,339 F3 embryos
and screened approximately 12,196.
We identified 24 mutant lines with 10 recessive mutant lines
having choroid plexus deformities. Time-lapse imaging show-
ing choroid plexus development for wild-type and some mutants
are demonstrated in Supplemental Movies 2–7. In addition to
choroid plexus deformities, each of the10 recessive lines had other
defects such as heart edema, small eyes, and small head. While
several of the mutants exhibited brain cell death, many did not
develop cell death until after the choroid plexus started to form.
A description of the onset of brain cell death for each line is
listed in Table 2. We also found spontaneous mutants that had
normal morphology overall, but severely abnormal or no choroid
plexus (data not shown). In addition, we found many mutants
(some recessive and some spontaneous) with severe brain cell
death and normal choroid plexus development (data not shown).
The choroid plexus mutant lines were named based on the orig-
inal F2 family and pair number within that family. No mutants
were adult viable and most did not survive past 4 dpf, except for
cp26.6 and cp105.2, which lived until 5 and 6 dpf, respectively.
cp27.5 and cp44.10 mutants displayed similar phenotypes; how-
ever, complementation analysis showed that they were not in the
same complementation group. On the basis of GFP intensity,
epithelial localization, and overall choroid plexus morphology,
we identified five classes: (I) mutants with reduced GFP expres-
sion, dispersed epithelial cells, and irregularly shaped choroid
plexus; (II) mutants with normal GFP expression, small epithelial
aggregates, and irregularly shaped choroid plexus; (III) mutants
with normal GFP expression, small epithelial aggregates, and
expanded choroid plexus; (IV)mutants with variable GFP expres-
sion, small epithelial aggregates, and expanded choroid plexus;
and (V) mutants with normal GFP expression, compact epithelial
cells, and enlarged choroid plexus. While complementation anal-
ysis was not performed between all of these mutants, we are fairly
certain that these mutations are in different genes. However, we
acknowledge that it is possible that different types of mutations in
the same gene from different mutants could result in additional
Frontiers in Neuroscience | Neurogenomics November 2014 | Volume 8 | Article 364 | 8
Henson et al. Zebrafish choroid plexus genetics
FIGURE 5 | The zebrafish CP is functional and possesses size-selective
properties. Casper zebrafish were intravenously injected with fluorescent
tracers at 2, 3, and 4 dpf to identify tracer leakage from blood into the
cerebrospinal fluid. (A) The top panel shows severe leakage of the 3-kDa
fluorescein dextran into the brain ventricle (inset) at 2 dpf, minor leakage at
3 dpf, and little, if any, dextran penetration at 4 dpf. The bottom panel shows
permeability of the 10-kDa rhodamine dextran at 2 dpf (inset), which
decreases by 4 dpf. The 40-kDa fluorescein dextran was the least permeable
at each developmental timepoint. Images were taken at 1 h post-injection.
(B) A ratio of fluorescence intensity in the brain ventricle relative to the heart
was measured at 30min post-injection as a readout for tracer leakage into
the brain ventricle. A One-Way ANOVA shows that the 3-kDa fluorescein
dextran and the 10-kDa rhodamine dextran are significantly more permeable
(i.e., greater mean fluorescence intensity) than the 40-kDa fluorescein
dextran at 2 and 3 dpf. By 4 dpf, there was no significant difference in
fluorescence intensity. Measurements are expressed as mean ± SE for
n = 7; ∗∗∗∗p < 0.0001. Abbreviations: Rhod, rhodamine dextran; Flour:
fluorescein dextran. Scale bar is 50μm.
phenotypes. A description of these mutants and choroid plexus
morphology are presented in Table 2 and Figure 7, respectively.
Wild-type Et(cp:EGFP)sj2 larvae at 3 and 4 dpf are shown
in Figures 7A–D′ as a reference to compare with mutant
classes.
To further classify these mutants, we analyzed brain ventricle
morphology and transporter activity in the choroid plexus. To
examine brain ventricle morphology, we injected a 40-kDa flu-
orescein dextran into the ventricle of Et(cp:EGFP)sj2 mutants that
were generated by outcrossing the mutant lines to the wild-type
TL strain, were GFP negative, and selected based upon pheno-
typic traits. Descriptions of brain ventricles and their morphology
are presented in Table 2 and Figure 7, respectively. None of the
mutants except cp26.6 and cp105.2 had normal ventricle mor-
phology, While some mutants such as cp79.6 and cp79.8 had
a third, fourth, and lateral ventricles, the shape or size of the
ventricle differed from wild-type. None of the mutants except
cp26.6 and cp105.2 had normal ventricle morphology. Severe
cases having no defined ventricular boundaries were observed in
mutants cp9.6, cp27.5, cp44.10, and cp151.2.
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FIGURE 6 | The zebrafish CP becomes size-selective as it develops.
(A) Et(cp:EGFP)sj2 larvae were intravenously injected with a 10 kDa
rhodamine-dextran and the CP was imaged dorsally by confocal microscopy.
At 2 dpf, the CP is not fully developed as observed by GFP expression and the
10 kDa rhodamine-dextran inundates the brain ventricle. By 4 dpf, the CP is fully
formed and the 10 kDa rhodamine-dextran is retained within the vasculature
and does not enter the brain ventricle. (B) A One-Way ANOVA analysis
revealed that the 3 kDa fluorescein dextran and 10 kDa rhodamine dextran
have a significantly higher fluorescent intensity in the brain ventricle (i.e., more
permeable) at 2 dpf compared to 3 and 4 dpf. There is no significant difference
between developmental time points for the 40 kDa fluorescein dextran.
Measurements are means ± SE for n = 7; ∗∗∗∗p < 0.0001. Scale bar is 50μm.
FLUORESCEIN ASSAY TO DETERMINE CHOROID PLEXUS TRANSPORT
Fluorescein transport was used as a secondary assay to measure
transporter activity in the choroid plexus and overall permeabil-
ity (refer to Figures 3G,H). To determine if the choroid plexus
could transport fluorescein in the mutants, larvae were treated
at 3 dpf with 50μM fluorescein as described above (Figure 8). In
Class I mutants, cp26.3 had fluorescein accumulation toward the
anterior part of the brain and no fluorescein accumulated within
the choroid plexus (Figure 8E). Fluorescein did not accumulate
in the choroid plexus epithelium in the cp140.2 mutant, but was
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Table 1 | Number of zebrafish generated from the forward genetic
screen.
Generation Fish (n)
G0 males mutagenized 20
G0 males survived 9
F1 409
F2 families started 224
F2 families screened 73
F2 × F2 crosses 1330
F2 families that spawned 421
F3 embryos screened 12,196
Mutants lines identified 24
Mutant lines maintained 10
localized throughout the brain ventricle. These mutants also had
a higher overall fluorescein uptake than wildtype. (Figure 8M).
In Class II mutants, cp9.6mutants also exhibited a higher over-
all uptake of fluorescein than wild-type and concentrated within
the brain ventricle, gut, and heart. There was no distinct accu-
mulation within the choroid plexus (Figure 8F). For cp79.6, the
overall uptake of fluorescein was comparable to wild-type. We
observed very faint punctate accumulate of fluorescein within the
general area of the choroid plexus indicating possible transport
(Figure 8N).
Class III mutants (cp79.8 and cp151.2) had increased uptake
of fluorescein compared to wild-type and both had accumulation
within the brain ventricle, gut, and heart. No fluorescein accu-
mulated within the choroid plexus epithelium (Figures 8G–O).
A similar phenotype was observed in Class IV mutants (cp27.5
and cp44.10) in that they also had increased uptake of fluorescein
concentrated within the brain ventricle, gut, and heart, but no
localization within choroid plexus epithelium (Figures 8H–P).
We were not able conclude whether Class V mutants (cp26.6 and
cp105.2) demonstrated transport activity using this assay because
of the inability to confidently identify GFP negative mutants at
3 and 4 dpf. Once we identified mutants by late 4–5 dpf, the flu-
orescein was rapidly cleared by the gut and was not distributed
throughout the embryo (data not shown).
GENETIC MAPPING OF cp9.6 AND cp27.5
To identify the mutated gene for lines cp9.6 and cp27.5, which
displayed hydrocephaly phenotypes, we performed genetic map-
ping using 192 polymorphicmarkers distributed evenly across the
genome. By bulked segregant analysis, we found linkage tomarker
z3275 that mapped cp9.6 to chromosome 4. With z3275, we
tested 100 mutants and identified 4 recombinants in 200 meiotic
events. The critical interval along the chromosome was defined
by recombination analysis. We identified polymorphic markers
on either side of z3275, z23802, and z15751; however, the lack
of additional polymorphic markers within this region made it
difficult to define a reasonable mapping distance.
For cp27.5, we identified markers z2363 and z15891 by bulked
segregant analysis to map the mutation to chromosome 21.
Within this critical interval, we identified the marker z9233
and found no recombinants out of 48 meioses. We then tested
additional polymorphic markers and counted the number of
recombinants on either side of z9233 to refine the critical interval.
By testing polymorphic markers, BX530031.5 and BX530023.5,
that we selected from the zebrafish genome published in Ensembl
Zv9, we narrowed the region to ∼0.4Mb. In total, we analyzed
450 meioses. Future analysis will include testing candidate genes
within this interval to identify the mutated gene.
DISCUSSION
The goal of our study was to establish zebrafish as a func-
tionally relevant model to study choroid plexus development
and as a screening tool to genetically dissect genes involved in
choroid plexus formation, function, and maintenance. Although
the choroid plexus has been studied in various in vivo and
in vitro models (Dohrmann, 1970; Strazielle and Preston, 2003),
the developmental and genetic aspects of this structure remain
poorly understood largely due to the lack of innovative strategies
and functionally relevant systems (Saunders et al., 2008). Also,
current models do not easily allow for choroid plexus develop-
ment to be visualized in real time. To overcome this limitation,
we created an enhancer trap zebrafish line, Et(cp:EGFP)sj2, which
expresses EGFP within the diencephalic choroid plexus and mye-
lencephalic choroid plexus. Using this line, choroid plexus devel-
opment was easily observed in a live vertebrate by monitoring
EGFP expression.
Previous studies have also generated enhancer trap lines in
zebrafish expressing GFP in the choroid plexus (Bill et al., 2008;
Garcia-Lecea et al., 2008). However, there are variations within
these lines, including the subsets of cells expressing GFP. For
example, in the EtMn16 line (Bill et al., 2008), only a subset
of cells of the myelencephalic choroid plexus express GFP. In
addition, the SqET33-E20 (Gateways) line has additional GFP
expression in the rhombomeres (Garcia-Lecea et al., 2008). In
our study, there was specific GFP expression in the diencephalic
choroid plexus, myelencephalic choroid plexus, and swimbladder.
In regards to GFP expression in the swimbladder, studies have
shown that Sonic hedgehog (Shh) is expressed in the epithelial
cells lining the swimbladder (Winata et al., 2009). Interestingly,
the choroid plexus of other vertebrates has also been compared to
the mammalian lung in a study by Nielsen and Dymecki (2010)
demonstrating that Shh (also expressed in choroid plexus epithe-
lia) is required for the synchronized outgrowth of the choroid
plexus and fenestrated vasculature, similar to the need for Shh in
coordinating the outgrowth of the lung (Nielsen and Dymecki,
2010). Since the zebrafish swimbladder has been compared to
the mammalian lung (Winata et al., 2009), common underlying
developmental pathways, such as Shh, required in both choroid
plexus and swimbladder development, maybe be regulating GFP
expression in these tissues. The variations in other enhancer
trap lines may be due to transgenic DNA constructs integrating
into different regions of the genome. Our PCR and Southern
blot analysis revealed a single integration on chromosome 13.
In contrast, the Gateways line has a single insertion on chromo-
some 24 (Garcia-Lecea et al., 2008), which likely accounts for the
differences in expression patterns between lines. Similar to the
previously published zebrafish choroid plexus papers (Bill et al.,
2008; Garcia-Lecea et al., 2008), we were unable to identify the
www.frontiersin.org November 2014 | Volume 8 | Article 364 | 11
Henson et al. Zebrafish choroid plexus genetics
Table 2 | Characterization of Et(cp:EGFP) mutants generated from the forward genetic screen.
Class Allele Map
position
DPF Other phenotypes(4 dpf) Fluorescein
transport
Onset of brain
cell death (up
to 4dpf)
Initial
circulation loss
(up to 4dpf)
I: reduced GFP expression,
dispersed epithelia, and
irregularly shaped CP
cp26.3a ND 2–3 No swimbladder; brain and
tail cell death; brain ventricle
hemorrhaging; faint
heartbeat; no circulation; no
midbrain-hindbrain
boundaries
Accumulates within
third ventricle
3 dpf 3 dpf
cp140.2 ND 2 Small head; small eyes; no
swimbladder; heart edema;
brain cell death; faint
heartbeat and circulation;
slightly larger third ventricle
and wider lateral ventricles
ventricle
Increased uptake;
accumulates within
brain ventricle
4 dpf 4 dpf
II: normal GFP expression,
smaller epithelial aggregates,
and irregularly shaped CP
cp9.6 LG 4 2 Small head; small eyes; no
swimbladder; heart edema;
occasional hydrocephalus;
brain cell death; no
circulation; no distinct third
ventricle or lateral ventricles
and severely reduced fourth
ventricle
Increased uptake;
accumulates within
brain ventricle
2 dpf 4 dpf
cp79.6 ND 2 Small head; small eyes; no
swimbladder; heart edema;
many still in chorion; brain cell
death; hemorrhaging around
heart; slow heartbeat; little to
no circulation; wider lateral
ventricles
Dispersed punctate
staining on the
dorsal ventricle
surface
4 dpf 3 dpf
III: normal GFP expression,
smaller epithelial aggregates,
and expanded CP
cp79.8 ND 2 Small head; small eyes; no
swimbladder; brain cell
death; hemorrhaging around
heart; decreased heartbeat
and circulation; wider lateral
ventricles
Increased uptake;
accumulates within
brain ventricle
4 dpf 3 dpf
cp151.2 ND 2–3 Small head; small eyes; no
swimbladder; brain cell
death; minor swelling around
head; occasional
hemorrhaging around heart;
smaller third ventricle and no
defined lateral ventricles
Increased uptake;
accumulates within
brain ventricle
4 dpf 4 dpf
IV: variable GFP expression,
smaller epithelial aggregates,
and expanded CP
cp27.5 LG 21 2 Small head; small eyes; no
swimbladder; brain cell
death; heart edema; small
arched body; curved tail;
hydrocephalus; occasional
hemorrhaging in brain
ventricle; heartbeat, but little
to no circulation; no defined
ventricle boundaries
Increased uptake;
accumulates within
brain ventricle
2 dpf (localized
to forebrain)
3 dpf
(Continued)
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Table 2 | Continued
Class Allele Map
position
DPF Other phenotypes(4 dpf) Fluorescein
transport
Onset of brain
cell death (up
to 4dpf)
Initial
circulation loss
(up to 4dpf)
cp44.10 ND 2 Small head; small eyes; no
swimbladder; brain cell
death; heart edema; small
arched body; curved tail;
hydrocephalus; occasional
hemorrhaging around heart;
heartbeat, but little to no
circulation; no third ventricle
or lateral ventricles and
irregularly shaped fourth
ventricle
Increased uptake;
accumulates within
brain ventricle
2 dpf (localized
to forebrain)
4 dpf
V: normal GFP expression,
compact epithelia, and
enlarged CP
cp26.6b ND 4 Rounded head, protruding
lower jaw; no swimbladder;
edema around heart, eyes,
and gut; faint heartbeat and
circulation; normal brain
ventricle
N/A N/A 4dpf
cp105.2b ND 4–5 Rounded head, protruding
lower jaw; no swimbladder;
severe edema around heart,
eyes, and gut; faint heartbeat
and circulation; slightly
smaller fourth ventricle
N/A N/A 6dpf
aObservations recorded at 3 dpf; bobservations recorded at 5 dpf; ND, not determined; N/A, not applicable.
enhancer regulating GFP expression in the choroid plexus. This is
often true with enhancer trap effects where is difficult to identify
the enhancer if it acts at distances upstream or downstream of the
reporter gene.
We have demonstrated blood-cerebrospinal fluid barrier prop-
erties in zebrafish by identifying tight junction proteins and
transporter activity. We have shown Cldn5 expression within
the choroid plexus and demonstrated that the zebrafish choroid
plexus possess a chemical barrier that transports and concentrates
rhodamine 123 and fluorescein in the choroid plexus epithelium.
Rhodamine 123 directly interacts with MRP1 and MDR1 in an
ATP-dependent manner (Shapiro and Ling, 1998; Daoud et al.,
2000). Because previous studies have shown the specificity of
rhodamine 123 to multidrug resistance proteins (MDRs), simi-
lar drug transporters are likely expressed in the zebrafish choroid
plexus. Studies in mice have identified known transporters of
rhodamine 123 such as MRP1 to be localized at the basolat-
eral side of choroid plexus epithelium and have been shown
to keep drugs such as etoposide out of the cerebrospinal fluid
(Wijnholds et al., 2000; Keep and Smith, 2011). Our findings also
confirm that transporters are present in the zebrafish choroid
plexus by showing that: when coming from the bloodstream,
rhodamine 123 accumulates within the choroid plexus and is
prevented from entering the cerebrospinal fluid. When injected
directly into the cerebrospinal fluid, the choroid plexus removed
rhodamine 123 from the fluid as shown by dye accumulation
within choroid plexus epithelium. Unfortunately, due to the lack
of antibodies that cross-react with zebrafish proteins, we were
unable to demonstrate the expression of specific transporters
in the zebrafish choroid plexus. We tested an antibody against
MDR1 (C219), but found expression only within brain endothe-
lial cells of the blood-brain barrier (Umans and Taylor, 2012) and
not the choroid plexus (data not shown). We also tested several
commercially available antibodies against OAT3, but none cross-
reacted with zebrafish. Additionally, while we did not observe
Glut1 expression within the zebrafish choroid plexus, a recent
review by Keep and Smith indicated that the BBB, not the
blood-cerebrospinal fluid barrier, may be the major source of
transporting glucose into the brain and that the choroid plexus
may play a minor role in glucose transport (Keep and Smith,
2011).
We demonstrated barrier function in the zebrafish choroid
plexus by injecting fluorescent tracers of different molecular
weights and observing permeability across the choroid plexus
epithelium into the cerebrospinal fluid. Once the choroid plexus
fully formed by 4 dpf, the smallest tracer tested, a 3-kDa flu-
orescein dextran, was no longer permeable across the blood-
cerebrospinal fluid barrier as it was in earlier developmental
stages. This result indicated a tightening of the barrier as it devel-
ops. Although we did not distinguish between transcellular and
paracellular transport, there appears to be a correlation between
choroid plexus formation and decreased permeability, suggesting
that a physical barrier is preventing molecule entry rather than
being cleared by a cerebrospinal fluid drainage pathway. For
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FIGURE 7 | Forward genetic screen identifies five classes of CP mutants.
(A–B′) Wild-type Et(cp:EGFP)sj2 larvae at 3 dpf and 4 dpf. (C–C′) Bright field
image of 3 and 4 dpf wild-type after ventricle injection of the 40-kDa
fluorescein dextran. (D–D′) Fluorescent image of 3 and 4 dpf wild-type after
ventricle injection of the 40-kDa fluorescein dextran. Class I: (E,F) cp26.3 at
3 dpf. (E′,F′) cp140.2 at 4 dpf. (G) Bright field image of cp26.3 at 3 dpf after
ventricle injection of the 40-kDa fluorescein dextran. (G′) Bright field
(Continued)
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FIGURE 7 | Continued
image of cp140.2 at 3 dpf after ventricle injection of the 40-kDa fluorescein
dextran. (H) Fluorescent image of cp26.3 at 3 dpf after ventricle injection of
the 40-kDa fluorescein dextran. (H′) Fluorescent image of cp140.2 at 3 dpf
after ventricle injection of the 40-kDa fluorescein dextran. Class II: (I,J) cp9.6
at 4 dpf. (I′,J′) cp79.6 at 4 dpf. (K) Bright field image of cp9.6 at 3 dpf after
ventricle injection of the 40-kDa fluorescein dextran. (K′) Bright field image of
cp79.6 at 3 dpf after ventricle injection of the 40-kDa fluorescein dextran.
(L) Fluorescent image of cp9.6 at 3 dpf after ventricle injection of the 40-kDa
fluorescein dextran. (L′) Fluorescent image of cp79.6 at 3 dpf after ventricle
injection of the 40-kDa fluorescein dextran. Class III: (M,N) cp79.8 at 4 dpf.
(M′,N′) cp151.2 at 4 dpf. (O) Bright field image of cp79.8 at 3 dpf after
ventricle injection of the 40-kDa fluorescein dextran. (O′) Bright field image of
cp151.2 at 3 dpf after ventricle injection of the 40-kDa fluorescein dextran.
(P) Fluorescent image of cp79.8 at 3 dpf after ventricle injection of the
40-kDa fluorescein dextran. (P′) Fluorescent image of cp151.2 at 3 dpf after
ventricle injection of the 40-kDa fluorescein dextran. Class IV: (Q,R) cp27.5 at
4dpf. (Q′,R′) cp44.10 at 4 dpf. (S) Bright field image of cp27.5 at 3 dpf after
ventricle injection of the 40-kDa fluorescein dextran. (S′) Bright field image of
cp44.10 at 3 dpf after ventricle injection of the 40-kDa fluorescein dextran.
(T) Fluorescent image of cp27.5 at 3 dpf after ventricle injection of the 40-kDa
fluorescein dextran. (T′) Fluorescent image of cp44.10 at 3 dpf after ventricle
injection of the 40-kDa fluorescein dextran. Class V: (U,V) cp26.6 at 4 dpf.
(U′,V′) cp105.2 at 4 dpf. (W) Bright field image of cp26.6 at 4 dpf after
ventricle injection of the 40-kDa fluorescein dextran. (W′) Bright field image
of cp105.2 at 4 dpf after ventricle injection of the 40-kDa fluorescein dextran.
(X) Fluorescent image of cp26.6 at 4 dpf after ventricle injection of the
40-kDa fluorescein dextran. (X′) Fluorescent image of cp105.2 at 4 dpf after
ventricle injection of the 40-kDa fluorescein dextran. The first, third, and
fourth panels for each class are dorsal views while the second panel is a
lateral view. The first and second panels for each class were acquired by
confocal microscopy. The third and fourth panels were acquired by
fluorescent stereoscopy. The first panel for each class is at 20×
magnification, the second panel is at 10× magnification, and the third and
fourth panels are at 16× magnification. 40 kDa Fluor, 40 kDa Fluorescein
Dextran. Scale bars in A, B, and C are 50μm.
example, this is demonstrated when we injected the 40-kDa tracer
into the bloodstream on day 4 and never observed tracer accumu-
lation within the ventricle throughout the course of the timelapse.
Rather than suggesting that the tracer is being cleared from the
ventricle by cerebrospinal fluid flow, we observed that the tracer
never entered the ventricle in the first place. This indicated to
us that a physical barrier is preventing the dextran from cross-
ing the barrier. Had we observed accumulation of the dextran
within the cerebrospinal fluid/brain ventricle after injection, and
then observed a decrease in the amount of tracer in the ventricle
over time, then we would suggest that cerebrospinal fluid flow is
the contributing factor and not a physical blockage of the dex-
tran by the barrier as we observed. In immature brain barriers,
it has been reported that the accumulation of molecules within
the cerebrospinal fluid is not due to increased permeability of
the barrier but reduced cerebrospinal fluid flow (Saunders et al.,
2008). In contrast, more mature brain barriers have increased
cerebrospinal fluid flow that limits the accumulation of molecules
within the ventricular space (Saunders et al., 2008). Our study
showed that after the formation of the choroid plexus there was
no tracer penetration into the ventricle. Therefore, a decrease in
tracer accumulation in the brain ventricle does not appear to be
due to increased cerebrospinal fluid clearance, but due to physical
barrier properties of the choroid plexus. The decrease in bar-
rier permeability as the choroid plexus develops establishes the
zebrafish choroid plexus as a functioning organ with size-selective
barrier properties.
Forward genetic screens have been performed in various mul-
ticellular organisms such as plants (Meinke and Sussex, 1979),
flies (Nusslein-Volhard and Wieschaus, 1980), worms (Sin et al.,
2014), zebrafish (Driever et al., 1996), and mice (Nolan et al.,
2000). These screens have been very successful in discovering
genes involved in embryonic patterning, organ development, and
behavior (Stemple et al., 1996; Horvitz, 1999; Muto et al., 2005).
To characterize the mutants in our study, we examined not only
GFP expression in the choroid plexus but also ventricle mor-
phology and transporter activity. Previous studies have grouped
zebrafish brain ventricle mutants into four categories: midline
separation defects, reduced ventricle size, lateral ventricles and
fourth ventricle abnormalities, and absence of lumen inflation
(Lowery et al., 2009). Because none of our choroid plexusmutants
exhibited a phenotype at 24 hpf, we did not expect to see defects in
midline separation as described in Lowery et al. (2009). Choroid
plexus mutants such as cp79.6 and cp140.2 have a brain ventricle
that closely resembles normal larvae at 2 dpf (Lowery et al., 2007),
indicating these mutants may have a developmental delay and
not necessarily a brain ventricle defect. Also, cp140.2 mutants at
3 dpf are similar to wild-type larvae at 2 dpf in that the fluorescein
accumulated within the brain ventricle rather than concentrating
within choroid plexus epithelium as it does normally on day 3.
Many mutants exhibited an increased overall uptake of fluores-
cein, which may indicate defects in the skin epithelial barrier as
well and increased permeability to absorb small molecules from
their surroundings.
While mutants exhibit little to no heart beat and circulation
when screened on day 4, as described in Table 2, the majority of
mutants do have a strong heart beat and rapid circulation indis-
tinguishable from wild-type prior to this timepoint. The initial
onset of circulation loss describes when we first observed mutants
with decreased or no circulation. Not all of the mutants had loss
of circulation at the same time, but the onset describes when we
observed the first mutant from a spawn having no circulation.
Because most began to have decreased heartbeat and circula-
tion at 4 dpf after the choroid plexus has already developed, we
conclude that other factors are regulating choroid plexus devel-
opment. However, we cannot rule out that circulation is required
for choroid plexus maintenance. We also do not attribute the lack
of blood flow to abnormal choroid plexus development, because
we identified spontaneous mutants with a normal choroid plexus
but no circulation (data not shown). After injecting single-cell
embryos with a cardiac troponin morpholino to block heartbeat
(Sehnert et al., 2002), we identified no choroid plexus defects
resembling abnormalities of the five mutant classes (data not
shown). Therefore, we conclude that if loss of circulation alone
was the factor governing abnormal choroid plexus development
in these mutants, we should see a choroid plexus that resembled
that of troponin morphants. Because many mutants continued to
have a heartbeat and circulation at 3 dpf, which is essential for
brain ventricle expansion (Lowery and Sive, 2005), we also did
not expect ventricle expansion defects in these mutants. While
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FIGURE 8 | Fluorescein assay determines CP transport activity in
mutants. (A–D) and (I–L) Wild-type larvae treated at 3 dpf with 50μM
fluorescein. (E) cp26.3 mutant at 3 dpf. (F) cp9.6 mutant at 3 dpf. Inset
image is acquired at the same exposure to the corresponding wild-type in
(B). (G) cp79.8 mutant at 3 dpf. Inset image is acquired at the same
exposure to the corresponding wild-type in (C). (H) cp27.5 mutant at 3 dpf.
Inset image is acquired at the same exposure to the corresponding
wild-type in (D). (M) cp140.2 mutant at 3 dpf. (N) cp79.6 mutant at 3 dpf.
Punctate accumulation of fluorescein in the brain ventricle is shown with
an arrowhead. (O) cp151.2 mutant at 3 dpf. Inset image is acquired at the
same exposure to the corresponding wild-type in (K). (P) cp44.10 mutant
at 3 dpf. Inset image is acquired at the same exposure to the
corresponding wild-type in (L). The larger images for (F,G,H,O,P) were
taken at a lower exposure compared to the corresponding wild-type in
order to visualize where the fluorescein was concentrating throughout the
larvae. Scale bar is 50μm.
ventricle morphology varied between mutants, all had expanded
ventricles.
The mutants identified in our screen will provide the tools
necessary to investigate several genes associated with choroid
plexus development and barrier function. After isolating the
defective genes from these mutants, we can define the correlation
between the genes involved and the phenotypic abnormalities
we observed. Although we identified mutants with brain cell
death, we do not contribute cell death alone as a factor respon-
sible for abnormal choroid plexus development and believe that
the processes can be unrelated. This is supported by the iden-
tification of larvae with brain cell death developed a normal
choroid plexus. Furthermore, for the mutants we characterized
further, we did not observe the onset of cell death until after
the choroid plexus had already started to develop for many
of the lines, or if cell death was present, it was not near the
choroid plexus itself. We also found larvae that had normal
morphology overall, but abnormal or no choroid plexus indi-
cating again that cell death is not the sole mechanism responsi-
ble for abnormal choroid plexus development and that specific
pathways exist in regulation choroid plexus formation and
function.
We expect some of the genes we identify will be specifi-
cally related to a choroid plexus defect rather than housekeep-
ing genes causing an overall severely abnormal animal. Recent
discoveries have shed light on the importance of the choroid
plexus and its contribution to disease. For example, transcrip-
tome analysis during early development revealed that the choroid
plexus expresses numerous genes essential for choroid plexus
function, including those for tight junctions, transporters, and
metabolic function (Liddelow et al., 2012), protecting the brain
from potentially harmful insults (Kratzer et al., 2013). Previous
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studies have also identified genetic components associated with
choroid plexus dysfunction and disease. Genes involved in these
pathologies include Polycystin-1 deficiency, which contributes to
hydrocephaly (Wodarczyk et al., 2009). Because some types of
hydrocephalus can be congenital, we plan to look at the mutant
lines displaying hydrocephalus-like phenotypes with expanded
ventricles (e.g., cp27.5 and cp9.6) and determine whether we
can find genetic linkage to this phenotype. In addition, muta-
tions in Twist-related protein-1 and constitutively active Notch
3 promote proliferation and invasion in choroid plexus tumors
(Wolburg and Paulus, 2010). Furthermore, disruption of the
blood-cerebrospinal fluid barrier in multiple sclerosis can cause
inflammation and leakage of T lymphocytes into the cere-
brospinal fluid (Vercellino et al., 2008; Wolburg and Paulus,
2010). In patients with Alzheimer’s disease, the choroid plexus
has decreased function in amyloid beta plaque clearance (Alvira-
Botero and Carro, 2010; Wolburg and Paulus, 2010). Since the
mutations in the choroid plexus lines we identified are embry-
onic lethal, they may not be good representations to model later
life diseases such as multiple sclerosis or Alzheimer’s disease.
However, we can investigate whether the choroid plexus is com-
promised in these mutants in regards to specific aspects of these
diseases, such as an increased influx of immune cells into the
cerebrospinal fluid characterized in multiple sclerosis, or reduced
cerebrospinal fluid flow found in Alzheimer’s disease patients.
Identifying the genetic mutations that produce similar patholo-
gies of these diseases may provide insight into the mechanisms
that occur in the choroid plexus at later stages in life for these
conditions.
The choroid plexus mutants identified in our study will be
used to identify genes essential for maintaining epithelial bar-
rier integrity as well as genes essential for initial barrier for-
mation. Reverse genetic studies have shown that transcription
factors such as Otx2 aid in choroid plexus development and
maintenance (Johansson et al., 2013). Also, augurin, a protein
encoded by the esophageal cancer related gene-4 (Ecrg4) and
thought to act as a tumor suppressor, has a higher expression in
the choroid plexus than other tissues. Interestingly, morpholino
knockdown of Ecrg4 in zebrafish results in increased central
nervous system cell proliferation and hydrocephaly (Gonzalez
et al., 2011). Additional studies in zebrafish showed that the clus-
terin gene, which encodes a secreted glycoprotein that aids in
aggregation and contributes to Alzheimer’s disease by colocal-
izing with plaques (Thambisetty et al., 2010), is similar to its
human counterpart and is expressed in the diencephalic choroid
plexus and myelencephalic choroid plexus (Jiao et al., 2011).
Demonstrating the similarity in gene expression in zebrafish
and human choroid plexus is important when considering the
use of zebrafish as a disease model for choroid plexus-related
conditions. Our study provides evidence that the barrier prop-
erties and function of zebrafish choroid plexus are similar to
those of mammalian choroid plexus. Ultimately, the genes dis-
covered from our choroid plexus mutants will provide a bet-
ter understanding of the genetic and molecular mechanisms
involved in choroid plexus formation and function and new
insights into how these normal processes become altered in
disease.
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